IP Library › Assignment 066178/0521
Patent Assignment
Reel/Frame 066178/0521

Assignment of Assignor's Interest

Recorded: 2024-01-02 Pages: 6
Assignor
Assignee
HEALIS THERAPEUTICS, INC.
4041 MACARTHUR BLVD., SUITE 400, NEWPORT BEACH, CALIFORNIA, 92660
Covered Properties (16)
Treatment of Social Anxiety Disorder, Obsessive Compulsive Disorder and Panic Disorder Using Botulinum Toxin
Method of Treating Depression
Patent: 7,758,872 →
Application: 10/773,785 →
Method for Treating Depression
Patent: 8,414,902 →
Application: 12/813,373 →
Publication: US 2010/0249036
System for Routing Interactions Using Bio-Performance Attributes of Persons as Dynamic Input
Patent: 9,060,064 →
Application: 13/625,814 →
Publication: US 2013/0136250
Treatment of Social Anxiety Disorder, Obsessive Compulsive Disorder and Panic Disorder Using Botulinum Toxin
Patent: 9,254,314 →
Application: 14/538,503 →
Publication: US 2015/0132282
Method of Treating Depression
Patent: 9,533,029 →
Application: 14/746,299 →
Publication: US 2015/0290302
Treatment of Social Anxiety Disorder, Obsessive Compulsive Disorder and Panic Disorder Using Botulinum Toxin
Application: 14/984,299 →
Publication: US 2016/0114015
Treatment of Social Anxiety Disorder Using Botulinum Toxin
Patent: 9,808,515 →
Application: 15/277,909 →
Publication: US 2017/0014493
Method of Treating Depression
Patent: 9,950,045 →
Application: 15/388,840 →
Publication: US 2017/0100465
Treatment of Social Anxiety Disorder, Obsessive Compulsive Disorder and Panic Disorder Using Botulinum Toxin
Application: 15/725,178 →
Publication: US 2018/0043000
Method of Treating Depression
Application: 15/957,494 →
Publication: US 2018/0236050
Treatment of Social Anxiety Disorder, Obsessive Compulsive Disorder and Panic Disorder Using Botulinum Toxin
Application: 16/233,003 →
Publication: US 2019/0365873
Method of Treating Depression
Application: 17/001,447 →
Publication: US 2020/0384091
Treatment of Panic Disorder Using Botulinum Toxin
Application: 17/084,833 →
Publication: US 2021/0046167
Method of treating depression
Application: 60/445,868 →
Treatment of Social Anxiety Disorder, Obsessive Compulsive Disorder and Panic Disorder Using Botulinum Toxin
Application: 61/903,292 →
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Patent Release (Reel:031644/Frame:0814) Dec 2, 2016
From: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
To: GENESYS TELECOMMUNICATIONS LABORATORIES, INC., AS GRANTOR; ANGEL.COM INCORPORATED; UTOPY, INC.; SOUNDBITE COMMUNICATIONS, INC.
Reel/Frame 040798/0428 →
Security Agreement Dec 5, 2016
From: GENESYS TELECOMMUNICATIONS LABORATORIES, INC., AS GRANTOR; ECHOPASS CORPORATION; INTERACTIVE INTELLIGENCE GROUP, INC.; BAY BRIDGE DECISION TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 040815/0001 →
Corrective Release for Security Interest in Patents Originally Recorded at Reel/Frame (029778/0939) Feb 27, 2017
From: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR TO THE ORIGINAL COLLATERAL AGENT GOLDMAN SACHS BANK USA
To: GENESYS TELECOMMUNICATIONS LABORATORIES, INC.; ANGEL.COM INCORPORATED; UTOPY, INC.; SOUNDBITE COMMUNICATIONS, INC.
Reel/Frame 041821/0209 →
Assignment of Assignor's Interest Sep 20, 2019
From: FINZI, ERIC; ROSENTHAL, NORMAN E
To: MARYLAND MENTAL HEALTH INSTITUTE
Reel/Frame 050446/0153 →
Assignment of Assignor's Interest Feb 28, 2022
From: FINZI, ERIC
To: MARYLAND MENTAL HEALTH INSTITUTE, LLC
Reel/Frame 059124/0089 →
Change of Name May 13, 2024
From: GENESYS TELECOMMUNICATIONS LABORATORIES, INC.
To: GENESYS CLOUD SERVICES, INC.
Reel/Frame 067390/0340 →
Notice of Succession of Security Interests at Reel/Frame 040815/0001 Feb 3, 2025
From: BANK OF AMERICA, N.A., AS RESIGNING AGENT
To: GOLDMAN SACHS BANK USA, AS SUCCESSOR AGENT
Reel/Frame 070498/0001 →